about
Long-term non-pharmacological weight loss interventions for adults with prediabetesPharmacotherapy for weight loss in adults with type 2 diabetes mellitusLong-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitusAssociation of an intensive lifestyle intervention with remission of type 2 diabetes.Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) studyDiabetes: how are we diagnosing and initially managing it?Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006Activity patterns of obese adults with type 2 diabetes in the look AHEAD study.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.Change in medical spending attributable to diabetes: national data from 1987 to 2011.Collecting data to assess SARS interventions.Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) StudyImpact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysisPrevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study.A1C level and future risk of diabetes: a systematic reviewAdded sugar intake and cardiovascular diseases mortality among US adults.Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.Socioeconomic and demographic predictors of selected cardiovascular risk factors among adults living in Pohnpei, Federated States of Micronesia.Prevalence of diabetic retinopathy in the United States, 2005-2008.The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes.Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.Performance of A1C for the classification and prediction of diabetes.Implications of alternative definitions of prediabetes for prevalence in U.S. adults.Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study.Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM projectLong-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008.Diabetes performance measures: current status and future directions.Varying modulation of HIV-1 LTR activity by Baf complexes.A comparison of cardiometabolic risk factors in households in rural Uganda with and without a resident with type 2 diabetes, 2012-2013.Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012Translating the science of primary, secondary, and tertiary prevention to inform the public health response to diabetes.Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011.Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study.The evolving diabetes burden in the United States.Diabetes translation research: where are we and where do we want to be?
P50
Q24244294-7090649F-1200-4D5A-9BB4-94E35121911EQ24245173-73E4E78E-227F-4121-95BF-DB1B031026D2Q24246952-5F65C161-F405-4147-BCB9-1F1BC83F703EQ27347992-1C3E33FA-B83B-42D9-AB4B-EBA30BE771D9Q28193551-51BF5531-9751-471C-87AB-2D44DED86EFDQ28194756-69530D60-F762-4A71-9F3D-0438984CB30AQ28196337-496DBA31-0BD0-48BB-B13A-2241EE17F389Q30202787-7C8A46BE-E5AF-4691-9109-2932588489BAQ30496729-5EB93A5B-9BAB-4A06-88F8-8270ECFEA2FEQ30548796-9345CC71-BD12-46EC-B24A-16BF25A138D9Q30884564-87F8935C-1B8C-477F-8B08-5256189AA6B0Q30953203-3026EDAA-395D-46BC-95E2-FAB9A300651BQ33304233-9DE179B0-19E5-4E3B-AEB5-0892EE16F0BEQ33646647-DFF4DB9F-7AFF-4B8C-94B4-DE9048852377Q33663474-757C4521-8EDD-4F6F-8514-4CB205E276F7Q33683691-0CD9595F-E361-4881-95E0-0859FF52B0EFQ33751603-2D210BAD-CF7F-4F79-B12F-100AE5513BF1Q33932887-4CB81A98-33E1-454A-AE8A-FD6927708CABQ34039753-11DB092E-C8D8-4FAB-957A-F15B93E86449Q34073450-4B2A741F-209E-4E3B-9ED9-4C3CC7FEBDAEQ34151489-6DB436EF-B83D-4700-94C3-6C9CD6AD5740Q34154127-2C8FF253-84F6-4E1F-8EAC-6A78B1574704Q34219386-026E7691-4827-4C75-B9D1-A731C4B27690Q34321390-239BD59B-F29E-4052-9888-45809875D0C9Q34422138-F8AAB3AD-F9F8-43E7-986F-E2EE00B4E637Q34507171-2AC57F16-3BBF-41CC-9635-F7859FF1B167Q34724785-AB256F46-00D8-4D9D-AABE-814FA0782945Q34882597-6BCB4CC0-E1D5-44F7-96A6-270E77F9349FQ35060134-25358B9C-C8F3-4D2B-8E15-EC595B8CEDC1Q35060223-597A14A7-8CA1-4869-B15F-E40501D35D1EQ35136646-48F6C29A-6CDB-498C-A752-EF88610A9847Q35250125-52225543-D27F-4545-9CE4-661D181DB16BQ35558490-F66C77B5-0B2B-4389-901E-B29637456851Q35608363-C4E2C744-7C31-451A-9B16-34387A440F99Q35688229-A6F85C36-AF71-40B6-8B6A-7FCD39854A60Q35689542-E5C1E686-7CAA-4B4A-96DC-EF78AE09184FQ35739808-8C2F97EC-B757-4952-B418-3BB4B4469F86Q35769490-043D9582-15CA-476E-8455-6649A81A9402Q35789756-DFD377A1-FA5F-42B1-900C-1C7087EB2447Q35789765-D985085D-B5C0-4508-A6FD-ADD31AAC0707
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Edward W Gregg
@ast
Edward W Gregg
@en
Edward W Gregg
@es
Edward W Gregg
@nl
type
label
Edward W Gregg
@ast
Edward W Gregg
@en
Edward W Gregg
@es
Edward W Gregg
@nl
altLabel
Edward Gregg
@en
prefLabel
Edward W Gregg
@ast
Edward W Gregg
@en
Edward W Gregg
@es
Edward W Gregg
@nl
P106
P1153
56693008300
P21
P31
P496
0000-0003-2381-6822